Torbjörn Bjerke has served as a member of DBV’s Board of Directors since 2006. Dr. Bjerke is currently the portfolio manager of Arctic Aurora LifeScience and a director of TXP Pharma GmbH. He previously served as the President and Chief Executive Officer of Karolinska Development AB from 2011 to 2014. Prior to that, Dr. Bjerke was the President and Chief Executive Officer of Orexo AB, a position he held from 2007 until January 2011. Previously, he was President and Chief Executive Officer of Biolipox AB, Executive Vice President, R&D, ALK Pharmaceuticals, and Director of Pharmacology at AstraZeneca. Dr. Bjerke holds a Ph.D. in Medicine from Aarhus Universitet.